Keep a close eye on this high-quality multibagger stock which is on the verge of breakout!

The stock has delivered a whopping 179 per cent returns in just a matter of 19 weeks. Speciality chemicals grew by 18 per cent while nutrition & health solutions advanced 13 per cent.

Jubilant Ingrevia is a global integrated life science products & innovative solutions provider serving the pharmaceutical, nutrition, agrochemical, consumer, and industrial customers with customised products & solutions that are innovative, cost-effective, and conforming to excellent quality standards.   

The stock has delivered a whopping 179 per cent returns in just a matter of 19 weeks. Recently, the company announced its Q1FY22 results wherein, it reported a growth of 55 per cent YoY in the total revenue from operations. Speciality chemicals grew by 18 per cent while nutrition & health solutions advanced 13 per cent but life science chemicals performance stood out as it witnessed a staggering growth of 103 per cent on a YoY basis. Besides, life sciences chemical revenue growth was driven by higher volume as well as prices.   

The stock is on the verge of a breakout of a 14-day base and interestingly, it is trading above all its important moving averages despite the chaos in the markets. Hence, keep a close watch on this multibagger stock, which is on the verge of a breakout.   

The stock is up by 8 per cent on a week-to-date basis while on a month-to-date basis, it is up by 11 per cent.   

Meanwhile, the big bull of D-Street i.e. Rakesh Jhunjhunwala along with this wife, Rekha has over 6 per cent of stake in the company.